<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Annang FB</submitter><funding>Regional Government of Andalusia</funding><funding>Plan Nacional</funding><funding>Instituto de Salud Carlos III</funding><funding>Scientific and technological infrastructures from the Ministerio de Ciencia e Innovación</funding><funding>Junta de Andalucía</funding><pagination>492</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9962372</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>&lt;i>Memnoniella&lt;/i> is a fungal genus from which a wide range of diverse biologically active compounds have been isolated. A &lt;i>Memnoniella dichroa&lt;/i> CF-080171 extract was identified to exhibit potent activity against &lt;i>Plasmodium falciparum&lt;/i> 3D7 and &lt;i>Trypanosoma cruzi&lt;/i> Tulahuen whole parasites in a high-throughput screening (HTS) campaign of microbial extracts from the Fundación MEDINA's collection. Bioassay-guided isolation of the active metabolites from this extract afforded eight new meroterpenoids of varying potencies, namely, memnobotrins C-E (&lt;b>1&lt;/b>-&lt;b>3&lt;/b>), a glycosylated isobenzofuranone (&lt;b>4&lt;/b>), a tricyclic isobenzofuranone (&lt;b>5&lt;/b>), a tetracyclic benzopyrane (&lt;b>6&lt;/b>), a tetracyclic isobenzofuranone (&lt;b>7&lt;/b>), and a pentacyclic isobenzofuranone (&lt;b>8&lt;/b>). T</pubmed_abstract><journal>Pharmaceutics</journal><pubmed_title>Antiparasitic Meroterpenoids Isolated from &lt;i>Memnoniella dichroa&lt;/i> CF-080171.</pubmed_title><pmcid>PMC9962372</pmcid><funding_grant_id>INP-2011-0016-PCT-010000 ACT6</funding_grant_id><funding_grant_id>PCT-01000-ACT7, 2011-13</funding_grant_id><funding_grant_id>SAF PID2019-109623RB-I00</funding_grant_id><funding_grant_id>BIO-199</funding_grant_id><funding_grant_id>RD16/0027/0015</funding_grant_id><funding_grant_id>PCT-010000-2010-4 (NMR)</funding_grant_id><funding_grant_id>SAF2016-79957-R</funding_grant_id><funding_grant_id>RD16/0027/0014</funding_grant_id><funding_grant_id>RD12/0018/0005</funding_grant_id><funding_grant_id>Grants Nos. PCT- 010000-2010-4 (NMR), INP-2011-0016-PCT-010000 ACT6 and PCT-01000-ACT7, 2011-13</funding_grant_id><funding_grant_id>RICET: RD16/0027/0014, RD16/0027/0015, and RD12/0018/0005</funding_grant_id><funding_grant_id>SAF PID2019-109623RB-I00; SAF2016-79957-R</funding_grant_id><pubmed_authors>Annang FB</pubmed_authors><pubmed_authors>Bosch-Navarrete C</pubmed_authors><pubmed_authors>Gonzalez-Menendez V</pubmed_authors><pubmed_authors>Martin J</pubmed_authors><pubmed_authors>Ruiz-Perez LM</pubmed_authors><pubmed_authors>Ramos MC</pubmed_authors><pubmed_authors>Reyes F</pubmed_authors><pubmed_authors>Mackenzie TA</pubmed_authors><pubmed_authors>Genilloud O</pubmed_authors><pubmed_authors>Gonzalez-Pacanowska D</pubmed_authors><pubmed_authors>Perez-Moreno G</pubmed_authors><pubmed_authors>Vicente F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antiparasitic Meroterpenoids Isolated from &lt;i>Memnoniella dichroa&lt;/i> CF-080171.</name><description>&lt;i>Memnoniella&lt;/i> is a fungal genus from which a wide range of diverse biologically active compounds have been isolated. A &lt;i>Memnoniella dichroa&lt;/i> CF-080171 extract was identified to exhibit potent activity against &lt;i>Plasmodium falciparum&lt;/i> 3D7 and &lt;i>Trypanosoma cruzi&lt;/i> Tulahuen whole parasites in a high-throughput screening (HTS) campaign of microbial extracts from the Fundación MEDINA's collection. Bioassay-guided isolation of the active metabolites from this extract afforded eight new meroterpenoids of varying potencies, namely, memnobotrins C-E (&lt;b>1&lt;/b>-&lt;b>3&lt;/b>), a glycosylated isobenzofuranone (&lt;b>4&lt;/b>), a tricyclic isobenzofuranone (&lt;b>5&lt;/b>), a tetracyclic benzopyrane (&lt;b>6&lt;/b>), a tetracyclic isobenzofuranone (&lt;b>7&lt;/b>), and a pentacyclic isobenzofuranone (&lt;b>8&lt;/b>). T</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-04-08T13:16:36.272Z</modification><creation>2024-10-19T01:03:07.544Z</creation></dates><accession>S-EPMC9962372</accession><cross_references><pubmed>36839814</pubmed><doi>10.3390/pharmaceutics15020492</doi></cross_references></HashMap>